Boris Zanolari

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

Amina Haouala, Boris Zanolari, Bertrand Rochat et al. · Journal of Chromatography B · 2009 · 202 citations

Therapeutic Drug Monitoring, Medicinal Chemistry, Medicine +10

Multiplex Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification in Human Plasma of Fluconazole, Itraconazole, Hydroxyitraconazole, Posaconazole, Voriconazole, Voriconazole- <i>N</i> -Oxide, Anidulafungin, and Caspofungin

Laurent A. Décosterd, Bertrand Rochat, Benoît Pesse et al. · Antimicrobial Agents and Chemotherapy · 2010 · 119 citations · Full text

Efficient Tdm, Biological Mass Spectrometry, Clinical Mycology +26

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Aurélie Fayet, Alexandre Béguin, Boris Zanolari et al. · Journal of Chromatography B · 2009 · 118 citations

Neurovirology, Antiviral Drug Development, Antiviral Therapy +8

A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma

Eva Maria Hodel, Boris Zanolari, Thomas Mercier et al. · Journal of Chromatography B · 2009 · 116 citations

Antiparasitic Agent, Biological Mass Spectrometry, Metabolomic Profiling +17

Qualitative and quantitative determination of yohimbine in authentic yohimbe bark and in commercial aphrodisiacs by HPLC‐UV‐API/MS methods

Boris Zanolari, Karine Ndjoko, Jean‐Robert Ioset et al. · Phytochemical Analysis · 2003 · 42 citations